Austin Murata

Array ( [id] => 5580501 [patent_doc_number] => 20090175847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'HUMANIZED ANTIBODIES TO AB (20-42) GLOBULOMER AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/129469 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 42171 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175847.pdf [firstpage_image] =>[orig_patent_app_number] => 12129469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791573 [patent_doc_number] => 20080292546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER' [patent_app_type] => utility [patent_app_number] => 12/127636 [patent_app_country] => US [patent_app_date] => 2008-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 64350 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292546.pdf [firstpage_image] =>[orig_patent_app_number] => 12127636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508003 [patent_doc_number] => 20090081210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells' [patent_app_type] => utility [patent_app_number] => 12/125849 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 58215 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081210.pdf [firstpage_image] =>[orig_patent_app_number] => 12125849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452644 [patent_doc_number] => 20090068681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR RISK STRATIFICATION' [patent_app_type] => utility [patent_app_number] => 12/125759 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 42077 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068681.pdf [firstpage_image] =>[orig_patent_app_number] => 12125759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028593 [patent_doc_number] => 08143373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Carbohydrate-containing pan cancer marker' [patent_app_type] => utility [patent_app_number] => 12/599284 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9331 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143373.pdf [firstpage_image] =>[orig_patent_app_number] => 12599284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580438 [patent_doc_number] => 20090175784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Anti-Alpha V Immunoliposome Composition, Methods, and Uses' [patent_app_type] => utility [patent_app_number] => 12/118994 [patent_app_country] => US [patent_app_date] => 2008-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 25245 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175784.pdf [firstpage_image] =>[orig_patent_app_number] => 12118994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711064 [patent_doc_number] => 20080299590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'SHC protein-related methods and compositions' [patent_app_type] => utility [patent_app_number] => 12/151960 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 7495 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299590.pdf [firstpage_image] =>[orig_patent_app_number] => 12151960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309763 [patent_doc_number] => 20090017044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Antibodies to the Human Prolactin Receptor' [patent_app_type] => utility [patent_app_number] => 12/112587 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24810 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017044.pdf [firstpage_image] =>[orig_patent_app_number] => 12112587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948978 [patent_doc_number] => 20080305104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of TROP-2' [patent_app_type] => utility [patent_app_number] => 12/082647 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 29967 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305104.pdf [firstpage_image] =>[orig_patent_app_number] => 12082647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420180 [patent_doc_number] => 20100150918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'CROSS-SPECIES-SPECIFIC BINDING DOMAIN' [patent_app_type] => utility [patent_app_number] => 12/594713 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 171 [patent_figures_cnt] => 171 [patent_no_of_words] => 89414 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150918.pdf [firstpage_image] =>[orig_patent_app_number] => 12594713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663582 [patent_doc_number] => 20080254489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR RISK STRATIFICATION' [patent_app_type] => utility [patent_app_number] => 12/061565 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 42121 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254489.pdf [firstpage_image] =>[orig_patent_app_number] => 12061565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10182557 [patent_doc_number] => 09212230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-15 [patent_title] => 'Bispecific antibodies and methods for production thereof' [patent_app_type] => utility [patent_app_number] => 12/593759 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 39 [patent_no_of_words] => 27890 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886913 [patent_doc_number] => 20080261245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'ANTIBODIES, INCLUDING FV MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/055145 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17399 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261245.pdf [firstpage_image] =>[orig_patent_app_number] => 12055145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284869 [patent_doc_number] => 20090098544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'MARKER MOLECULES ASSOCIATED WITH LUNG TUMORS' [patent_app_type] => utility [patent_app_number] => 12/050002 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 18616 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098544.pdf [firstpage_image] =>[orig_patent_app_number] => 12050002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710588 [patent_doc_number] => 20080299114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'HUMANEERED ANTI-FACTOR B ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/049233 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17291 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299114.pdf [firstpage_image] =>[orig_patent_app_number] => 12049233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995221 [patent_doc_number] => 08519106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Monoclonal human tumor-specific antibody' [patent_app_type] => utility [patent_app_number] => 12/530764 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14269 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12530764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4821761 [patent_doc_number] => 20080227122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'P2Y PURINERGIC RECEPTOR EXPRESSION FOR IDENTIFYING PRENEOPLASTIC AND NEOPLASTIC STATES' [patent_app_type] => utility [patent_app_number] => 12/043083 [patent_app_country] => US [patent_app_date] => 2008-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5222 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227122.pdf [firstpage_image] =>[orig_patent_app_number] => 12043083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866816 [patent_doc_number] => 20080145875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'ANTI-TENASCIN MONOCLONAL ANTIBODY IMMUNOASSAYS AND DIAGNOSTIC KITS' [patent_app_type] => utility [patent_app_number] => 12/035328 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6183 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145875.pdf [firstpage_image] =>[orig_patent_app_number] => 12035328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391178 [patent_doc_number] => 20090208491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 12/031293 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27376 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208491.pdf [firstpage_image] =>[orig_patent_app_number] => 12031293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954510 [patent_doc_number] => 20080187534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/021232 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30295 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187534.pdf [firstpage_image] =>[orig_patent_app_number] => 12021232 [rel_patent_id] =>[rel_patent_doc_number] =>)